Drug
Dazodalibep
Dazodalibep: highest development phase Phase 3, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dazodalibep NCT06104124 | Phase 3 | Sjogren's Syndrome |
Latest
No recent events.
Follow Dazodalibep on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.